{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:01:39Z","timestamp":1750737699021,"version":"3.41.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970533"],"award-info":[{"award-number":["81970533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022ZD21"],"award-info":[{"award-number":["ZR2022ZD21"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2507500"],"award-info":[{"award-number":["2023YFC2507500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10620-025-09000-3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:00:55Z","timestamp":1743847255000},"page":"2138-2146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Outcomes of Carvedilol Plus Endoscopic Variceal Ligation in Secondary Prophylaxis of Variceal Bleeding"],"prefix":"10.1007","volume":"70","author":[{"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"9000_CR1","first-page":"21","volume":"30","author":"XM Li","year":"2022","unstructured":"Li XM, Luo BH, Wang ZY, Yuan J, Han GH. Baveno VII - Renewing consensus in portal hypertension: personalized care for portal hypertension. Zhonghua Gan Zang Bing Za Zhi. 2022;30:21\u201329.","journal-title":"Zhonghua Gan Zang Bing Za Zhi."},{"key":"9000_CR2","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","volume":"79","author":"DE Kaplan","year":"2024","unstructured":"Kaplan DE, Ripoll C, Thiele M et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2024;79:1180\u20131211.","journal-title":"Hepatology"},{"key":"9000_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017;65:310\u2013335.","journal-title":"Hepatology"},{"key":"9000_CR4","first-page":"1517","volume":"21","author":"MC Hou","year":"1995","unstructured":"Hou MC, Lin HC, Kuo BI et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology. 1995;21:1517\u20131522.","journal-title":"Hepatology."},{"key":"9000_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u2013752.","journal-title":"J Hepatol."},{"key":"9000_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.510300124","volume":"30","author":"R Ba\u00f1ares","year":"1999","unstructured":"Ba\u00f1ares R, Moitinho E, Piqueras B et al. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology. 1999;30:79\u201383.","journal-title":"Hepatology."},{"key":"9000_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1665-2681(19)30849-X","volume":"13","author":"N Aguilar-Olivos","year":"2014","unstructured":"Aguilar-Olivos N, Motola-Kuba M, Candia R et al. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: systematic review and meta-analysis. Ann Hepatol. 2014;13:420\u2013428.","journal-title":"Ann Hepatol."},{"key":"9000_CR8","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","volume":"62","author":"T Reiberger","year":"2013","unstructured":"Reiberger T, Ulbrich G, Ferlitsch A et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 2013;62:1634\u20131641.","journal-title":"Gut."},{"key":"9000_CR9","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","volume":"393","author":"C Villanueva","year":"2019","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J et al. \u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393:1597\u20131608.","journal-title":"Lancet."},{"key":"9000_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/MCG.0000000000001431","volume":"55","author":"GN Kalambokis","year":"2021","unstructured":"Kalambokis GN, Christaki M, Tsiakas I et al. Conversion of propranolol to carvedilol improves renal perfusion and outcome in patients with cirrhosis and ascites. J Clin Gastroenterol. 2021;55:721\u2013729.","journal-title":"J Clin Gastroenterol."},{"key":"9000_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jceh.2020.08.009","volume":"11","author":"S Sharma","year":"2021","unstructured":"Sharma S, Agarwal S, Gunjan D et al. Long-term outcomes with carvedilol versus propranolol in patients with index variceal bleed: 6-year follow-up study. J Clin Exp Hepatol 2021;11:343\u2013353.","journal-title":"J Clin Exp Hepatol"},{"key":"9000_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12072-016-9765-y","volume":"11","author":"V Gupta","year":"2017","unstructured":"Gupta V, Rawat R, Saraya A. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1\u00a0month in patients with index variceal bleed: RCT. Hepatol Int 2017;11:181\u2013187.","journal-title":"Hepatol Int"},{"key":"9000_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/apt.16189","volume":"53","author":"HR McDowell","year":"2021","unstructured":"McDowell HR, Chuah CS, Tripathi D, Stanley AJ, Forrest EH, Hayes PC. Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up study. Aliment Pharmacol Ther. 2021;53:531\u2013539.","journal-title":"Aliment Pharmacol Ther."},{"key":"9000_CR14","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.cgh.2022.06.007","volume":"21","author":"M Jachs","year":"2023","unstructured":"Jachs M, Hartl L, Simbrunner B et al. Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis. Clin Gastroenterol Hepatol. 2023;21:2318-2326.e7.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9000_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20131457.","journal-title":"Lancet."},{"key":"9000_CR16","doi-asserted-by":"crossref","unstructured":"Corrigendum to \"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis\" [J Hepatol 69 (2018) 406\u2013460]. J Hepatol. 2018. 69(5): p. 1207.","DOI":"10.1016\/j.jhep.2018.08.009"},{"key":"9000_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/hep.20339","volume":"40","author":"N Carbonell","year":"2004","unstructured":"Carbonell N, Pauwels A, Serfaty L, Fourdan O, L\u00e9vy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652\u2013659.","journal-title":"Hepatology."},{"key":"9000_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMra0901512","volume":"362","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823\u2013832.","journal-title":"N Engl J Med."},{"key":"9000_CR19","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/gutjnl-2015-309262","volume":"64","author":"D Tripathi","year":"2015","unstructured":"Tripathi D, Stanley AJ, Hayes PC et al. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680\u20131704.","journal-title":"Gut."},{"key":"9000_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli P, Bernardi M et al. Villanueva: EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u2013460.","journal-title":"J Hepatol."},{"key":"9000_CR21","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/ajg.2016.327","volume":"111","author":"SG Kim","year":"2016","unstructured":"Kim SG, Kim TY, Sohn JH et al. A randomized, multi-center, open-label study to evaluate the efficacy of carvedilol vs. propranolol to reduce portal pressure in patients with liver cirrhosis. Am J Gastroenterol. 2016;111:1582\u20131590.","journal-title":"Am J Gastroenterol."},{"key":"9000_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jhep.2022.12.005","volume":"78","author":"A Albillos","year":"2023","unstructured":"Albillos A, Krag A. Beta-blockers in the era of precision medicine in patients with cirrhosis. J Hepatol. 2023;78:866\u2013872.","journal-title":"J Hepatol."},{"key":"9000_CR23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.14309\/01.ajg.0001033364.19047.90","volume":"119","author":"B Wang","year":"2024","unstructured":"Wang B, Zhou J, Wu X et al. Carvedilol plus NUC for patients With HBV-compensated cirrhosis under virological suppression: a randomized open-label trial. Am J Gastroenterol. 2024;119:700\u2013711.","journal-title":"Am J Gastroenterol."},{"key":"9000_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","volume":"7","author":"CJ Alberts","year":"2022","unstructured":"Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, de Martel C. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 2022;7:724\u2013735.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"9000_CR25","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010. 53: p. 397\u2013417.","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"9000_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s12072-023-10536-7","volume":"17","author":"V Singh","year":"2023","unstructured":"Singh V, De A, Mehtani R et al. Asia-Pacific association for study of liver guidelines on management of ascites in liver disease. Hepatol Int. 2023;17:792\u2013826.","journal-title":"Hepatol Int."},{"key":"9000_CR27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/hep.1840360612","volume":"36","author":"R Ba\u00f1ares","year":"2002","unstructured":"Ba\u00f1ares R, Moitinho E, Matilla A et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology. 2002;36:1367\u20131373.","journal-title":"Hepatology."},{"key":"9000_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/1319-3767.164185","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Khandelwal N, Kalra N et al. Correlation of HVPG level with ctp score, MELD score, ascites, size of varices, and etiology in cirrhotic patients. Saudi J Gastroenterol. 2016;22:109\u2013115.","journal-title":"Saudi J Gastroenterol."},{"key":"9000_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-2036.2002.01190.x","volume":"16","author":"D Tripathi","year":"2002","unstructured":"Tripathi D, Therapondos G, Lui HF, Stanley AJ, Hayes PC. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther. 2002;16:373\u2013380.","journal-title":"Aliment Pharmacol Ther."},{"key":"9000_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0168-8278(99)80108-1","volume":"30","author":"AJ Stanley","year":"1999","unstructured":"Stanley AJ, Therapondos G, Helmy A, Hayes PC. Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis. J Hepatol. 1999;30:479\u2013484.","journal-title":"J Hepatol."},{"key":"9000_CR31","first-page":"1143","volume":"11","author":"KS Cheung","year":"2023","unstructured":"Cheung KS, Mok CH, Lam LK, Mao XH, Mak LY, Seto WK, Yuen MF. Carvedilol versus other nonselective beta blockers for variceal bleeding prophylaxis and death: a network meta-analysis. J Clin Transl Hepatol. 2023;11:1143\u20131149.","journal-title":"J Clin Transl Hepatol."},{"key":"9000_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jhep.2022.08.029","volume":"78","author":"Y Cho","year":"2023","unstructured":"Cho Y, Bukong TN, Tornai D, Babuta M, Vlachos IS, Kanata E, Catalano D, Szabo G. Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis. J Hepatol. 2023;78:28\u201344.","journal-title":"J Hepatol."},{"key":"9000_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070201","volume":"380","author":"L Muratori","year":"2023","unstructured":"Muratori L, Lohse AW, Lenzi M. Diagnosis and management of autoimmune hepatitis. Bmj. 2023;380:e070201.","journal-title":"Bmj."},{"key":"9000_CR34","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2023.05.017","volume":"79","author":"RS Khan","year":"2023","unstructured":"Khan RS, Lalor PF, Thursz M, Newsome PN. The role of neutrophils in alcohol-related hepatitis. J Hepatol. 2023;79:1037\u20131048.","journal-title":"J Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09000-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:48:22Z","timestamp":1750668502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09000-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9000"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09000-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read the final version of the manuscript and have approved for submission. I declare, on behalf of all authors, that the work described has not been published previously, and not under consideration for publication elsewhere, in whole or in part. We declare that there is no conflict of interest in connection with this study. This study was approved by the Biomedical Research Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}